FDA Increases OTC Monograph User Fees by 19 Percent for Fiscal 2022 Post author:PacConAdmin Post published:March 14, 2022 Post category:Drug Industry Daily The FDA has released its over-the-counter (OTC) monograph drug user fees for fiscal 2022. Source: Drug Industry Daily You Might Also Like Merck’s Keytruda Improves Survival for Esophageal Cancer Patients August 20, 2020 Zients Fronts Biden Administration’s Restructured Operation Warp Speed February 17, 2021 Advocacy Groups Appeal to HHS to Claim Patents and Negotiate Lower Drug Prices April 9, 2018